ELAN-Pilot Projects

P165-OA: Lipid nanoparticles for targeted delivery of HIV-1 antigens and genetic immunomodulators Jan. 1, 2025 - Dec. 31, 2025 P154-OA: Establishing an in vitro negative-pressure wound therapy (NPWT) model and analysing molecular effects of NPWT Jan. 1, 2025 - Dec. 31, 2025 P149: Podocyte specific targeting with functionalized drug loaded nanoparticles for precision medicine Jan. 1, 2025 - Dec. 31, 2025 P145: Impaired local and systemic Th17/Treg immune response in periodontitis July 1, 2024 - Dec. 31, 2025 P166: Role of C-terminal Binding Protein 1 (CTBP1) in Hippocampal Energetics Nov. 16, 2024 - Nov. 30, 2025 P157: Characterization of neoantigen-directed T-cell receptor-based cell therapies in a 3D breast cancer model Nov. 1, 2024 - Oct. 31, 2025 P147: Modelling the intestinal barrier to analyse HTLV-1 transmission Nov. 1, 2024 - Oct. 31, 2025 P151-OA: Nephronectin-Integrin: From podocyte nephronectin secretion into the ECM and back to podocyte integrity Oct. 1, 2024 - Sept. 30, 2025 P170: The impact of BC 007 on immune dysregulation in patients with Post-COVID syndrome Feb. 1, 2025 - Aug. 31, 2025 P156-OA: An App based, individualized High-Intensity Interval Training intervention for young Fontan patients Sept. 1, 2024 - Aug. 31, 2025